Insights

A&M Newsletters
Comprehensive and timely perspectives, on the topics that matter to you, sent straight to your inbox.
Created
Thought Leadership

Navigating Global Pharma Policy

November 4, 2025
As the U.S. considers imposing tariffs on European pharmaceutical imports, the ripple effects could be felt across the global healthcare landscape. For an industry already grappling with rising R&D costs and competitive pressures, these tariffs threaten to erode profit margins and disrupt finely tuned supply chains.
Thought Leadership

Owning the room when it wasn't built for you

November 4, 2025
Across the private equity ecosystem, women continue to be underrepresented. This article shares reflections from a recent panel discussion on authenticity, inclusive leadership and resilience.
Thought Leadership

David Gonski on AI and Inclusion

November 3, 2025
David Gonski AC reflects on the evolving responsibilities of boards in the age of AI, highlighting how AI must be approached not just as a technological shift, but as a strategic and ethical imperative.

Orthopaedic Products M&A Market

October 31, 2025
The global orthopaedics market is valued at $62 billion and is projected to reach $81 billion by 2030 at a 4.3% CAGR. In contrast, the UK market is expanding more rapidly, with a 6.5% CAGR, rising from $1.9 billion to $2.6 billion by 2030.
Case Studies

Case Study: Aareal Bank AG - inaugural SRT

October 31, 2025
A&M's Structured Credit Execution and Advisory team was the sole arranger for Aareal Bank AG’s (Aareal) first synthetic significant risk transfer (SRT) securitization referencing a €2 billion commercial real estate (CRE) portfolio partnering with funded and unfunded investors.